Cargando…

Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules

Assess computed tomography (CT) imaging characteristics after percutaneous cryotherapy for lung cancer. A retrospective IRB-approved analysis of 40 patients who underwent nonsurgical treatment for primary stage 1 lung cancer performed from January 2007 to March 2011 was included in this study. All p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhry, Ammar, Grechushkin, Vadim, Hoshmand, Mahsa, Kim, Choo Won, Pena, Andres, Huston, Brett, Chaya, Yair, Bilfinger, Thomas, Moore, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620810/
https://www.ncbi.nlm.nih.gov/pubmed/26496275
http://dx.doi.org/10.1097/MD.0000000000001672
_version_ 1782397359813033984
author Chaudhry, Ammar
Grechushkin, Vadim
Hoshmand, Mahsa
Kim, Choo Won
Pena, Andres
Huston, Brett
Chaya, Yair
Bilfinger, Thomas
Moore, William
author_facet Chaudhry, Ammar
Grechushkin, Vadim
Hoshmand, Mahsa
Kim, Choo Won
Pena, Andres
Huston, Brett
Chaya, Yair
Bilfinger, Thomas
Moore, William
author_sort Chaudhry, Ammar
collection PubMed
description Assess computed tomography (CT) imaging characteristics after percutaneous cryotherapy for lung cancer. A retrospective IRB-approved analysis of 40 patients who underwent nonsurgical treatment for primary stage 1 lung cancer performed from January 2007 to March 2011 was included in this study. All procedures were performed using general anesthesia and CT guidance. Follow-up imaging with CT of the chest was obtained at 1 month, 3 months, 6 months, and 12 months postprocedure to evaluate the ablated lung nodule. Nodule surface area, density (in Hounsfield units), and presence or absence of cavitations were recorded. In addition, the degree of nodule enhancement was also recorded. Patients who were unable to obtain the aforementioned follow-up were excluded from the study. Thirty-six patients underwent percutaneous cryoablation with men to women ratio of 75% with mean age for men 74.6 and mean age for women 74.3 years of age. The average nodule surface area preablation and postcryoablation at 1-, 3-, 6-, and 12-month follow-ups were 2.99, 7.86, 3.89, 3.18 and 3.07�cm(2), respectively. The average precontrast nodule density before cryoablation was 8.9 and average precontrast nodule density postprocedure at 1, 3, 6, and 12 months follow-ups were 8.5, −5.9, −9.4, and −3.8 HU, respectively. There is increased attenuation of lung nodules over time with an average postcontrast enhancement of 11.4, 18.5, 16.1, and 25.7 HU at the aforementioned time intervals. Cavitations occurred in the cryoablation zone in 53% (19/36) of patients. 80.6% (29/36) of the cavitations in the cryoablation zone resolved within 12 months. Four patients (11%) had recurrence of tumor at the site of cryoablation and none of the patients had satellite or distant metastasis. Our study shows that patients who underwent cryotherapy for lung nodules treatment had characteristic changes on follow-up CT including. The surface area of the nodule increases at the 1-month follow-up with subsequent gradual decrease in the surface area. Decreased nodule density (Hounsfield units) at each interval follow-up is associated with complete ablation of the lung cancer whereas increasing nodule density was suggestive of recurrence. Cavity formation within the region of the ablated nodule, most of which typically resolved within the first 3 to 6 months. Nodule enhancement is difficult to assess because of the limited data sets that are available.
format Online
Article
Text
id pubmed-4620810
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-46208102015-10-27 Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules Chaudhry, Ammar Grechushkin, Vadim Hoshmand, Mahsa Kim, Choo Won Pena, Andres Huston, Brett Chaya, Yair Bilfinger, Thomas Moore, William Medicine (Baltimore) 6700 Assess computed tomography (CT) imaging characteristics after percutaneous cryotherapy for lung cancer. A retrospective IRB-approved analysis of 40 patients who underwent nonsurgical treatment for primary stage 1 lung cancer performed from January 2007 to March 2011 was included in this study. All procedures were performed using general anesthesia and CT guidance. Follow-up imaging with CT of the chest was obtained at 1 month, 3 months, 6 months, and 12 months postprocedure to evaluate the ablated lung nodule. Nodule surface area, density (in Hounsfield units), and presence or absence of cavitations were recorded. In addition, the degree of nodule enhancement was also recorded. Patients who were unable to obtain the aforementioned follow-up were excluded from the study. Thirty-six patients underwent percutaneous cryoablation with men to women ratio of 75% with mean age for men 74.6 and mean age for women 74.3 years of age. The average nodule surface area preablation and postcryoablation at 1-, 3-, 6-, and 12-month follow-ups were 2.99, 7.86, 3.89, 3.18 and 3.07�cm(2), respectively. The average precontrast nodule density before cryoablation was 8.9 and average precontrast nodule density postprocedure at 1, 3, 6, and 12 months follow-ups were 8.5, −5.9, −9.4, and −3.8 HU, respectively. There is increased attenuation of lung nodules over time with an average postcontrast enhancement of 11.4, 18.5, 16.1, and 25.7 HU at the aforementioned time intervals. Cavitations occurred in the cryoablation zone in 53% (19/36) of patients. 80.6% (29/36) of the cavitations in the cryoablation zone resolved within 12 months. Four patients (11%) had recurrence of tumor at the site of cryoablation and none of the patients had satellite or distant metastasis. Our study shows that patients who underwent cryotherapy for lung nodules treatment had characteristic changes on follow-up CT including. The surface area of the nodule increases at the 1-month follow-up with subsequent gradual decrease in the surface area. Decreased nodule density (Hounsfield units) at each interval follow-up is associated with complete ablation of the lung cancer whereas increasing nodule density was suggestive of recurrence. Cavity formation within the region of the ablated nodule, most of which typically resolved within the first 3 to 6 months. Nodule enhancement is difficult to assess because of the limited data sets that are available. Wolters Kluwer Health 2015-10-23 /pmc/articles/PMC4620810/ /pubmed/26496275 http://dx.doi.org/10.1097/MD.0000000000001672 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 6700
Chaudhry, Ammar
Grechushkin, Vadim
Hoshmand, Mahsa
Kim, Choo Won
Pena, Andres
Huston, Brett
Chaya, Yair
Bilfinger, Thomas
Moore, William
Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules
title Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules
title_full Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules
title_fullStr Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules
title_full_unstemmed Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules
title_short Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules
title_sort characteristic ct findings after percutaneous cryoablation treatment of malignant lung nodules
topic 6700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620810/
https://www.ncbi.nlm.nih.gov/pubmed/26496275
http://dx.doi.org/10.1097/MD.0000000000001672
work_keys_str_mv AT chaudhryammar characteristicctfindingsafterpercutaneouscryoablationtreatmentofmalignantlungnodules
AT grechushkinvadim characteristicctfindingsafterpercutaneouscryoablationtreatmentofmalignantlungnodules
AT hoshmandmahsa characteristicctfindingsafterpercutaneouscryoablationtreatmentofmalignantlungnodules
AT kimchoowon characteristicctfindingsafterpercutaneouscryoablationtreatmentofmalignantlungnodules
AT penaandres characteristicctfindingsafterpercutaneouscryoablationtreatmentofmalignantlungnodules
AT hustonbrett characteristicctfindingsafterpercutaneouscryoablationtreatmentofmalignantlungnodules
AT chayayair characteristicctfindingsafterpercutaneouscryoablationtreatmentofmalignantlungnodules
AT bilfingerthomas characteristicctfindingsafterpercutaneouscryoablationtreatmentofmalignantlungnodules
AT moorewilliam characteristicctfindingsafterpercutaneouscryoablationtreatmentofmalignantlungnodules